Total, hemi, or dual-mobility arthroplasty for the treatment of femoral neck fractures in patients with neurological disease

Aims The aim of this study was to investigate the potentially increased risk of dislocation in patients with neurological disease who sustain a femoral neck fracture, as it is unclear whether they should undergo total hip arthroplasty (THA) or hemiarthroplasty (HA). A secondary aim was to investgate whether dual-mobility components confer a reduced risk of dislocation in these patients. Methods We undertook a longitudinal cohort study linking the Swedish Hip Arthroplasty Register with the National Patient Register, including patients with a neurological disease presenting with a femoral neck fracture and treated with HA, a conventional THA (cTHA) with femoral head size of ≤ 32 mm, or a dual-mobility component THA (DMC-THA) between 2005 and 2014. The dislocation rate at one- and three-year revision, reoperation, and mortality rates were recorded. Cox multivariate regression models were fitted to calculate adjusted hazard ratios (HRs). Results A total of 9,638 patients with a neurological disease who also underwent unilateral arthroplasty for a femoral neck fracture were included in the study. The one-year dislocation rate was 3.7% after HA, 8.8% after cTHA < 32 mm), 5.9% after cTHA (= 32 mm), and 2.7% after DMC-THA. A higher risk of dislocation was associated with cTHA (< 32 mm) compared with HA (HR 1.90 (95% confidence interval (CI) 1.26 to 2.86); p = 0.002). There was no difference in the risk of dislocation with DMC-THA (HR 0.68 (95% CI 0.26 to 1.84); p = 0.451) or cTHA (= 32 mm) (HR 1.54 (95% CI 0.94 to 2.51); p = 0.083). There were no differences in the rate of reoperation and revision-free survival between the different types of prosthesis and sizes of femoral head. Conclusion Patients with a neurological disease who sustain a femoral neck fracture have similar rates of dislocation after undergoing HA or DMC-THA. Most patients with a neurological disease are not eligible for THA and should thus undergo HA, whereas those eligible for THA could benefit from a DMC-THA. Cite this article: Bone Joint J 2022;104-B(1):134–141.

Electrode array design determines scalar position, dislocation rate and angle and postoperative speech perception

Purpose The aim of this study is to examine the scalar dislocation rate in straight and perimodiolar electrode arrays in relation to cochlear morphology. Furthermore, we aim to analyze the specific dislocation point of electrode arrays depending on their design and shape and to correlate these results to postoperative speech perception. Methods We conducted a comparative analysis of patients (ears: n = 495) implanted between 2013 and 2018 with inserted perimodiolar or straight electrode arrays from Cochlear™ or MED-EL. CBCT (cone beam computed tomography) was used to determine electrode array position (scalar insertion, intra-cochlear dislocation, point of dislocation and angular insertion depth). Furthermore, cochlear morphology was measured. The postoperative speech discrimination was compared regarding electrode array dislocation, primary scalar insertion and angular insertion depth. Results The electrode array with the highest rate of primary SV insertions was the CA; the electrode array with the highest rate of dislocations out of ST was the FlexSoft. We did not find significantly higher dislocation rates in cochleostomy-inserted arrays. The angle of dislocation was electrode array design-specific. A multivariate nonparametric analysis revealed that the dislocation of the electrode array has no significant influence on postoperative speech perception. Nevertheless, increasing angular insertion depth significantly reduced postoperative speech perception for monosyllables. Conclusion This study demonstrates the significant influence of electrode array design on scalar location, dislocation and the angle of dislocation itself. Straight and perimodiolar electrode arrays differ from each other regarding both the rate and place of dislocation. Insertion via cochleostomy does not lead to increased dislocation rates in any of the included electrode arrays. Furthermore, speech perception is significantly negatively influenced by angular insertion depth.

The Oxford Domed Lateral Unicompartmental Knee Replacement implant: Increasing wall height reduces the risk of bearing dislocation

Due to lateral ligament laxity, bearing dislocation occurs in 1%–6% of Oxford Domed Lateral replacements. Most dislocations are medial but they do rarely occur anteriorly or posteriorly. The aim was to decrease the risk of dislocation. For a bearing to dislocate the femoral component has to be distracted from the tibial component. A robotic-path-planning-algorithm was used with a computer model of the implant in different configurations to determine the Vertical Distraction needed for Dislocation (VDD). With current components, VDD anteriorly/posteriorly was 5.5 to 6.5 mm and medially was 3.5 to 5.75 mm. A thicker bearing increased VDD medially and decreased VDD anteriorly/posteriorly (0.1 mm/1 mm thickness increase). VDD medially increased with the bearing closer to the tibial wall (0.5 mm/1 mm closer), or by increasing the tibial wall height (1 mm/1 mm height increase). VDD anteriorly/posteriorly was not influenced by bearing position or wall height. To prevent collision between the femoral and tibial components an increase in wall height must be accompanied by a similar increase in minimum bearing thickness. Increasing the wall height and minimum bearing thickness by 2 mm and ensuring the bearing is 4 mm or less from the wall increased the minimum VDD medially to 5.5 mm. The lower VDD medially than anteriorly/posteriorly explains why medial dislocation is more common. If the wall height is increased by 2 mm, the minimum bearing thickness is 5 mm and the surgeon ensured the bearing is 4 mm or less from the wall, the medial dislocation rate should be similar to the anterior/posterior dislocation rate, which should be acceptable.

1049 Outcomes After Proximal Femoral Replacements in Metastatic Femoral Disease. A Systematic Review and Meta-Analysis

Aim The aim of the study was to assess outcomes after a proximal femoral replacement (PFR). More PFRs are being performed in accordance with the British Orthopaedic Oncology Society (BOOS) best practice guidance 2016. The population studied was patients with metastatic proximal femoral disease with actual or impending fractures. The intervention and comparator were PFR and intra-medullary nailing (IMN) respectively. The primary outcome was hospital readmission rate (all cause). Secondary outcomes were reoperation rate (all cause, infection) and dislocation rate. Method A literature search was performed in Medline, Embase, Web of Science and the Cochrane Library. The search strategy combined free and MeSH search terms related to population (e.g., “femoral neoplasms” OR “pathological femoral fracture”), intervention and comparator (e.g., “osteosynthesis” “surgery” OR “proximal femoral replacement ”). To pool the outcome data of the studies Freeman–Tukey double arcsine transformation was used. Readmission rates were generated based on complications requiring absolute hospital admission. Results After exclusions, the search provided 12 studies. The pooled rate of hospital readmission (all cause) was 0.08 (95% CI 0.04 - 0.12) (Figure 2). The pooled rate of reoperation (all cause), reoperation for infection and dislocation rate was 0.05 (95% CI 0.03 – 0.08), 0.01 (95% CI 0.00 – 0.04) and 0.02 (95% CI 0.00 – 0.05) respectively. Conclusions Following a PFR for proximal metastatic femoral disease, patients have low rates of hospital readmission and reoperation. Compared to IMN, reoperations are performed for deep infection and dislocations. The major complication with IMNs of metalwork fatigue and failure is overcome with the use of PFRs.

Dislocation rates following total hip arthroplasty via the direct anterior approach in a consecutive, non-selective cohort

Aims Use of the direct anterior approach (DAA) for total hip arthroplasty (THA) has increased in recent years due to proposed benefits, including a lower risk of dislocation and improved early functional recovery. This study investigates the dislocation rate in a non-selective, consecutive cohort undergoing THA via the DAA without any exclusion or bias in patient selection based on habitus, deformity, age, sex, or fixation method. Methods We retrospectively reviewed all patients undergoing THA via the DAA between 2011 and 2017 at our institution. Primary outcome was dislocation at minimum two-year follow-up. Patients were stratified by demographic details and risk factors for dislocation, and an in-depth analysis of dislocations was performed. Results A total of 2,831 hips in 2,205 patients were included. Mean age was 64.9 years (24 to 96), mean BMI was 29.2 kg/m2 (15.1 to 53.8), and 1,595 patients (56.3%) were female. There were 11 dislocations within one year (0.38%) and 13 total dislocations at terminal follow-up (0.46%). Five dislocations required revision. The dislocation rate for surgeons who had completed their learning curve was 0.15% compared to 1.14% in those who had not. The cumulative periprosthetic infection and fracture rates were 0.53% and 0.67%, respectively. Conclusion In a non-selective, consecutive cohort of patients undergoing THA via the DAA, the risk of dislocation is low, even among patients with risk factors for instability. Our data further suggest that the DAA can be safely used in all hip arthroplasty patients without an increased risk of wound complications, fracture, infection, or revision. The inclusion of seven surgeons increases the generalizability of these results. Cite this article: Bone Joint J 2021;103-B(7 Supple B):38–45.